Trial
NCT05304663
Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Philogen S.p.A.
Collaborators
—
Condition
Glioblastoma
Intervention
Onfekafusp alfa
Why stopped
The Sponsor had no further plan for the study in object
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-08